Ciprofloxacin and Moxifloxacin interaction
Ciprofloxacin and Moxifloxacin: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.
Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.
What the FDA labels say
From the Ciprofloxacin label · effective 2026-06-30
Click here to enter Contraindications Known hypersensitivity to ciprofloxacin or other quinolones ( 4.1 , 5.6, 5.7 )
Avoid use in patients with known prolongation, those with hypokalemia, and with other drugs that prolong the QT interval.
Ciprofloxacin, like other fluoroquinolones, is known to trigger seizures or lower the seizure threshold.
From the Moxifloxacin label · effective 2024-05-06
Known hypersensitivity to moxifloxacin or other quinolones.
Pharmacokinetic studies between moxifloxacin and other drugs that prolong the QT interval such as cisapride, erythromycin, antipsychotics, and tricyclic antidepressants have not been performed.
Drugs that Prolong QT There is limited information available on the potential for a pharmacodynamic interaction in humans between moxifloxacin and other drugs that prolong the QTc interval of the electrocardiogram.
Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.
Open in the checkerNot medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.